Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Cash from Financing Activities (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Cash from Financing Activities readings, the most recent being $19.8 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 74.16% to $19.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.3 million, a 240.17% increase, with the full-year FY2025 number at $38.3 million, up 66.74% from a year prior.
  • Cash from Financing Activities hit $19.8 million in Q4 2025 for SBC Medical Group Holdings, up from $11.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $19.8 million in Q4 2025 to a low of -$280380.0 in Q1 2025.
  • Median Cash from Financing Activities over the past 3 years was -$23321.5 (2023), compared with a mean of $4.9 million.
  • The widest YoY moves for Cash from Financing Activities: up 76302.37% in 2025, down 596.99% in 2025.
  • SBC Medical Group Holdings' Cash from Financing Activities stood at -$127221.0 in 2023, then surged by 9046.13% to $11.4 million in 2024, then skyrocketed by 74.16% to $19.8 million in 2025.
  • The last three reported values for Cash from Financing Activities were $19.8 million (Q4 2025), $11.6 million (Q3 2025), and $7.2 million (Q2 2025) per Business Quant data.